Identify High-Quality Small Molecule Drugs Faster

Drug discovery requires a multidisciplinary approach. BIOVIA’s end-to-end integrated solutions for Small Molecule Therapeutics Design are built over 30 years of expertise in research informatics, physics-based molecular modeling and simulation, and lab informatics. They facilitate collaboration across multidisciplinary research teams to design, discover and develop small molecule drugs faster at reduced costs.

A Scalable Cloud Solution

BIOVIA's solutions for Small Molecule Therapeutics Design are available as Software-as-a-Service (SaaS) applications, seamlessly integrated on the 3DEXPERIENCE platform. They can accommodate the research needs of both small teams and large pharmaceutical organizations, with the ability to:

  • Quickly deploy the newest solutions without hardware or IT investment
  • Customize data-driven workflows focused on unique requirements of individual research projects
  • Incorporate unique custom or third-party models, algorithms, and data sources.

From Virtual Design to Lab Synthesis

BIOVIA streamlines drug discovery by seamless integration of virtual lead identification and optimization methods with your own experimental design/testing in the lab:

  • Make predictions on “what to make next” using active learning
  • Democratize access to predictive models for increased efficiency
  • Ensure data integrity, security, traceability, and consistency throughout the drug development lifecycle.
     

State-of the-art Science with AI and Machine Learning

Build ML models easily, with your own lab data

Providing an easy to use, interactive user interface, BIOVIA Machine Learning Workbench facilitates high-quality model building for researchers with little or no data science background. These models are then used in BIOVIA Generative Therapeutics Design experiments to optimize lead compounds.

Orchestration of model training on a recurrent basis or when new data becomes available helps identify the best drug candidates, leveraging all assay data for improved predictive modeling.

Harness the Power of AI-Ready Data

Gain Insights from Data

Make fast, informed decisions on which compounds to synthesize for testing.

With BIOVIA Insight, scientists can visualize, analyze, and browse molecular data proposed by Generative Therapeutics Design in detail, together with calculated properties and experimentally derived data, and can compare chemical structures, properties or other custom visualizations, while collaborating seamlessly with other team members.

Start Your Journey

The world of Small Molecule Therapeutics Design is changing. Discover how to stay a step ahead with BIOVIA

FAQ About Small Molecule Drugs

Also Discover

Learn What BIOVIA Can Do for You

Speak with a BIOVIA expert to learn how our solutions enable seamless collaboration and sustainable innovation at organizations of every size.

Get Started

Courses and classes are available for students, academia, professionals and companies. Find the right BIOVIA training for you. 

Get Help

Find information on software & hardware certification, software downloads, user documentation, support contact and services offering